Join
Live feed
·
INSIDERFilingvia Quantisnow
Arcutis Biotherapeutics Inc. logo

SVP Chief Financial Officer Vairavan Latha sold $31,662 worth of shares (1,341 units at $23.61), decreasing direct ownership by 2% to 86,413 units (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARQT (Arcutis Biotherapeutics Inc.) and more on Quantisnow.

SVP Chief Financial Officer Vairavan Latha sold $31,662 worth of shares (1,341 units at $23.61), decreasing direct ownership by 2% to 86,413 units (SEC Form 4) (tax liability) | Quantisnow